SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000938206-24-000006
Filing Date
2024-02-14
Accepted
2024-02-14 07:43:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G/A 50232
  Complete submission text file 0000938206-24-000006.txt   51857
Mailing Address 25 EAST ERIE ST CHICAGO IL 60611
Business Address 25 EAST ERIE ST CHICAGO IL 60611 3125873800
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000938206 (see all company filings)

IRS No.: 203634295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88403 | Film No.: 24632356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)